hims and hers glp-1 Affordability Safety: How & is Delivering a New Experience Through the Scale of Our Platform Hims & Hers Stock Tumbles
Description
Huge congratulations to the authors!
The CMS GLP-1 Bridge program is a notable step forward in expanding access to obesity treatments for Medicare beneficiaries
Methods This is a cohort study combining several population-wide databases and covering a Spanish population of five million inhabitants, including all adults with obesity who initiated treatment with either GLP-1RA or SGLT-2i for type 2 diabetes from 2015 to 2021
Additionally, these are not components of FDA-approved drugs and have not been found safe and effective for any condition.At this time, these drugs are only legally accessible to clinical trial patients
GLP-1 weight loss medications are now accessible without insurance through compounded pharmacy options
